Assertio Therapeutics Stock Investor Sentiment
| ASRT Stock | USD 0.71 0.00 0.000003% |
Slightly above 62% of all Assertio Therapeutics' private investors are looking to take a long position. The analysis of overall sentiment of trading Assertio Therapeutics stock suggests that some investors are interested at this time. Assertio Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Assertio Therapeutics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 62
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Assertio Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Assertio Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Assertio Historical Sentiment
Although Assertio Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Assertio, such as negative comments on social media and news outlets, may cause fear in the market and push Assertio Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Assertio.
Assertio |
Assertio Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Assertio Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Assertio Therapeutics that are available to investors today. That information is available publicly through Assertio media outlets and privately through word of mouth or via Assertio internal channels. However, regardless of the origin, that massive amount of Assertio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Assertio Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Assertio Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Assertio Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Assertio Therapeutics alpha.
Assertio Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Insider Trading | 01/02/2025 |
2 | Acquisition by Heather Mason of 25000 shares of Assertio Therapeutics at 0.97 subject to Rule 16b-3 | 01/10/2025 |
3 | Disposition of 19404 shares by Sam Schlessinger of Assertio Therapeutics subject to Rule 16b-3 | 01/21/2025 |
4 | Assertio Holdings faces Nasdaq delisting over share price rule - Investing.com | 01/29/2025 |
5 | Short Interest in Assertio Holdings, Inc. Declines By 6.5 | 02/03/2025 |
6 | Acquisition by Staple Peter D of 53750 shares of Assertio Therapeutics subject to Rule 16b-3 | 02/06/2025 |
7 | Disposition of 25000 shares by Ajay Patel of Assertio Therapeutics subject to Rule 16b-3 | 02/07/2025 |
8 | INVESTOR ALERT Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Optio... | 02/12/2025 |
9 | Acquisition by Ogrady Brendan P. of 500000 shares of Assertio Therapeutics subject to Rule 16b-3 | 02/18/2025 |
10 | Disposition of 17150 shares by Ajay Patel of Assertio Therapeutics subject to Rule 16b-3 | 02/21/2025 |
11 | Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March ... | 03/05/2025 |
12 | Assertio Holdings Non-GAAP EPS of -0.03 misses by 0.04, revenue of 32.1M beats by 3.43M | 03/12/2025 |
13 | Q4 2024 Assertio Holdings Inc Earnings Call Transcript | 03/13/2025 |
14 | Assertio Price Target Lowered to 3.50 at HC Wainwright | 03/19/2025 |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.